NCT02354924

Brief Summary

The purpose of this study is to demonstrate that the VISCO (Olifilcon A) soft contact lens could be prescribed as a supportive care for myopic persons.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 29, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 3, 2015

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

April 14, 2017

Completed
Last Updated

April 14, 2017

Status Verified

March 1, 2017

Enrollment Period

5 months

First QC Date

January 29, 2015

Results QC Date

November 1, 2016

Last Update Submit

March 2, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Acuity

    Visual acuity correctable to snellen 20/25 or better

    3 months

Secondary Outcomes (2)

  • Slit Lamp Findings

    3 month

  • Symptoms, Problems and Complaints and Incidence Rate

    3 month

Study Arms (2)

Visco soft contact lens

EXPERIMENTAL

Olifilcon A, Daily wear, monthly disposable soft contact lens

Device: Visco soft contact lens

Biofinity soft contact lens

ACTIVE COMPARATOR

Comfilcon A, Daily wear, monthly disposable soft contact lens

Device: Biofinity soft contact lens

Interventions

Biofinity soft contact lens on two eyes and follow up for 3 months (90 days). It is necessary to remove contact lenses every day and replace after 30 days.

Biofinity soft contact lens

Viso soft contact lens on two eyes and follow up for 3 months (90 days). It is necessary to remove contact lenses every day and replace after 30 days.

Visco soft contact lens

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject should have normal eyes and use no ocular medications
  • Subject with -1.00 to -10.00 D myopia, less than -1.25 D astigmatism
  • VA correctable to 20/25 or better.
  • Willing to comply with all study procedures and be available for the duration of the study.
  • Provide signed and dated informed consent form.

You may not qualify if:

  • Subjects have history of allergies that would contraindicate solution use and/or "normal" contact lens wear.
  • Cornea sensitivity low, high myopes, Keratoconus, dry eye with Schirmer Test \< 5mm/5min or other physical condition that would contraindicate contact lens wear.
  • Subjects have other active ocular or systemic disease that would contraindicate contact lens wear.
  • Subjects have medications that would contraindicate contact lens wear.
  • Females who are pregnant, breastfeeding, birth control pill taken or who intended to become pregnant over the course of the study.
  • Current drug or alcohol use or dependence that would interfere with adherence to study requirements.
  • Individuals participating in other clinical studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Dr. Huey-Chuan Cheng
Organization
Mackay Memorial Hospital_Taipei

Study Officials

  • Huey Chuan Cheng, MD. MS

    Mackey Memorial Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2015

First Posted

February 3, 2015

Study Start

June 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

April 14, 2017

Results First Posted

April 14, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share